Lacosamide Injection
Product Images NDC 72865-235

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 72865-235). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xlcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lacosamide-inj-aspiro (Lacosamide Inj Aspiro)

FDA Label Image

Lacosamide-inj-carton-label-10-mg-ml (Lacosamide Inj Carton Label 10 mg mL)

Lacosamide-inj-carton-label-10-mg-ml (Lacosamide Inj Carton Label 10 mg mL)
Lacosamide Injection, USP is a medication that is only for Intravenous Use. It comes in 10 x 20 mL Single-Dose Vials, with each vial containing 20 mL solution for infusion. The single-dose vial of 20 mL contains 200 mg lacosamide. The drug is manufactured by Aspiro Pharma Limited and Sold by XLCare Pharmaceuticals, Inc. The USUAL DOSAGE information is available in the package insert. It should be stored at 20° to 25°C (68° to 77°R); excursions permitted between 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. There's a Medication Guide available at the website mentioned in the last line of the text.*
FDA Label Image

Lacosamide-inj-fig-1 (Lacosamide Inj Fig 1)

Lacosamide-inj-fig-1 (Lacosamide Inj Fig 1)
This is a graph showing a seizure reduction of 21% for placebo and different doses of Lacosamide per day (200, 400, 600) over a period of 6 months. Statistically significant differences were observed between Lacosamide and placebo groups.*
FDA Label Image

Lacosamide-inj-fig-2 (Lacosamide Inj Fig 2)

Lacosamide-inj-fig-2 (Lacosamide Inj Fig 2)
This is a table showing responder rates, improvements, and worsening for patients in different groups taking placebo or different doses of lacosamide. The percentage of patients is also indicated.*
FDA Label Image

Lacosamide-inj-structure (Lacosamide Inj Structure)

FDA Label Image

Lacosamide-inj-vial-label-10-mg-ml (Lacosamide Inj Vial Label 10 mg mL)

Lacosamide-inj-vial-label-10-mg-ml (Lacosamide Inj Vial Label 10 mg mL)
This is a medication label for Lacosamide Injection, USP, manufactured by Aspiro Pharma Limited in India for XLCare Pharmaceuticals, Inc. The label provides information about dosage, storage, and manufacturing details, including the batch code and license number. It also includes a warning to keep the medication out of reach of children and a website where a medication guide is available. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). A US contact number is also provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.